Cannabis
PurMinds NeuroPharma to Present at Psychedelic Capital: Jan 2022 by Microdose on Thursday, January 27
Toronto, Ontario–(Newsfile Corp. – January 27, 2022) – PurMinds NeuroPharma, a Canadian neuroscience company pursuing breakthrough solutions for devastating neurological disorders with a special emphasis on neurodegenerative diseases, will be presenting at Psychedelic Capital: Jan 2022 by Microdose on Thursday, January 27.
Get Free Tickets Here: https://microdose.buzz/PURMINDS
The coupon code PURMINDS will also work upon checkout.
Date & Time of the Event: 01/27/2022 01:30pm EST
Date & Time of Their Panel: 01/27/2022 03:15pm EST
While the presentation is live streamed, lifetime access to recordings will be available to all ticket holders.
What is Psychedelic Capital: Jan 2022?
Psychedelic Capital covers the top companies, latest IPOs, newest opportunities & deepest insights in the psychedelic industry.
For more information, please visit: https://microdose.buzz/shop/events/psychedelic-capital/psychedelic-capital-jan-2022/
About PurMinds NeuroPharma
PurMinds NeuroPharma is pursuing breakthrough solutions for devastating neurological disorders with a special emphasis on neurodegenerative diseases. We strive to deliver the right drugs to the right patients by utilizing technology and championing next generation drug development approaches.
The key to discovering and developing better drugs is to understand the disease mechanism. The more we understand, the more effective our therapeutics will be at delivering the right drug to the right patient.
PurMinds’ PurPrecision™ neuromedicine development platform will be used to analyze iPSC-derived neurons from diseased patients and non-neurological healthy controls using multi-omics and integrative computational analyses.
PurMinds champions psychoactive pharmaceutical investigation and believes in the power of psychedelics as a useful tool and catalyst for next generation CNS drug development.
Contact
For any inquiries related to PurMinds NeuroPharma and any of their programs, you can visit their website at https://www.purminds.com/ or send an e-mail to [email protected].
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/111794
-
Cannabis1 week ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis1 week ago
IM Cannabis Reports First Quarter Financial Results
-
Innocan1 week ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
-
Cannabis5 days ago
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
-
Cannabis5 days ago
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis4 days ago
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
-
Cannabis3 days ago
Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032
-
Cannabis3 days ago
Rubicon Organics Reports Q1 2024 Financial Results